Results 161 to 170 of about 10,900 (261)

Discovery and molecular mechanism of potent neutralizing antibody from humanized mice with respiratory syncytial virus. [PDF]

open access: yesPLoS Pathog
Zhang Z   +11 more
europepmc   +1 more source

Informe técnico palivizumab inyectable

open access: yes, 2016
En base a la revisión de la información científica respecto al medicamento Palivizumab 50mg inyectable, el Equipo Técnico acuerda no incluirlo en la Lista Complementaria de medicamentos al Petitorio Nacional Único de Medicamentos Esenciales (PNUME) debido a que no reduce la mortalidad y no es costo efectivo.
openaire   +1 more source

Improvement in Palivizumab Administration in Severely Immunocompromised Children: A Single-institution Quality Improvement Initiative. [PDF]

open access: yesPediatr Qual Saf
Hijano DR   +12 more
europepmc   +1 more source

Recommendation for use of a long-acting monoclonal antibody to prevent respiratory syncytial virus infection in infants and young children. [PDF]

open access: yesClin Exp Pediatr
Choi SH   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy